685 related articles for article (PubMed ID: 9179301)
1. Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein.
Sticha KR; Sieg CA; Bergstrom CP; Hanna PE; Wagner CR
Protein Expr Purif; 1997 Jun; 10(1):141-53. PubMed ID: 9179301
[TBL] [Abstract][Full Text] [Related]
2. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
3. Over-expression, purification, and characterization of recombinant human arylamine N-acetyltransferase 1.
Wang H; Vath GM; Kawamura A; Bates CA; Sim E; Hanna PE; Wagner CR
Protein J; 2005 Feb; 24(2):65-77. PubMed ID: 16003948
[TBL] [Abstract][Full Text] [Related]
4. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
5. Hamster monomorphic arylamine N-acetyltransferase: expression in Escherichia coli and purification.
Bergstrom CP; Wagner CR; Ann DK; Hanna PE
Protein Expr Purif; 1995 Feb; 6(1):45-55. PubMed ID: 7756838
[TBL] [Abstract][Full Text] [Related]
6. Characterization of hamster recombinant monomorphic and polymorphic arylamine N-acetyltransferases: bioactivation and mechanism-based inactivation studies with N-hydroxy-2-acetylaminofluorene.
Sticha KR; Bergstrom CP; Wagner CR; Hanna PE
Biochem Pharmacol; 1998 Jul; 56(1):47-59. PubMed ID: 9698088
[TBL] [Abstract][Full Text] [Related]
7. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
8. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
9. Syrian hamster monomorphic N-acetyltransferase (NAT1) alleles: amplification, cloning, sequencing, and expression in E. coli.
Ferguson RJ; Doll MA; Rustan TD; Baumstark BR; Hein DW
Pharmacogenetics; 1994 Apr; 4(2):82-90. PubMed ID: 8081415
[TBL] [Abstract][Full Text] [Related]
10. Affinity alkylation of hamster hepatic arylamine N-acetyltransferases: isolation of a modified cysteine residue.
Cheon HG; Boteju LW; Hanna PE
Mol Pharmacol; 1992 Jul; 42(1):82-93. PubMed ID: 1635555
[TBL] [Abstract][Full Text] [Related]
11. Soluble expression in Escherichia coli, one-step purification, and characterization of Chinese hamster dihydrofolate reductase.
Fan YX; Wang B; Jing GZ
Protein Expr Purif; 1997 Mar; 9(2):246-52. PubMed ID: 9056490
[TBL] [Abstract][Full Text] [Related]
12. Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.
Mattano SS; Land S; King CM; Weber WW
Mol Pharmacol; 1989 May; 35(5):599-609. PubMed ID: 2725469
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein.
Yu PL; Zhao J; Yu M; Reid R; Santi DV
Protein Expr Purif; 1996 Aug; 8(1):23-7. PubMed ID: 8812831
[TBL] [Abstract][Full Text] [Related]
14. Sequential peptide affinity purification system for the systematic isolation and identification of protein complexes from Escherichia coli.
Babu M; Butland G; Pogoutse O; Li J; Greenblatt JF; Emili A
Methods Mol Biol; 2009; 564():373-400. PubMed ID: 19544035
[TBL] [Abstract][Full Text] [Related]
15. A self-cleavable sortase fusion for one-step purification of free recombinant proteins.
Mao H
Protein Expr Purif; 2004 Sep; 37(1):253-63. PubMed ID: 15294306
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of active PKB kinase from Escherichia coli.
Klein S; Geiger T; Linchevski I; Lebendiker M; Itkin A; Assayag K; Levitzki A
Protein Expr Purif; 2005 May; 41(1):162-9. PubMed ID: 15802234
[TBL] [Abstract][Full Text] [Related]
17. Stable expression and purification of a secreted human recombinant prethrombin-2 and its activation to thrombin.
Russo G; Gast A; Schlaeger EJ; Angiolillo A; Pietropaolo C
Protein Expr Purif; 1997 Jul; 10(2):214-25. PubMed ID: 9226718
[TBL] [Abstract][Full Text] [Related]
18. Preparation and affinity purification of a novel, biologically active, CNTF fusion protein.
Rabinovsky ED; Browder DP; McManaman JL
J Neurosci Res; 1994 Jun; 38(2):127-33. PubMed ID: 8078097
[TBL] [Abstract][Full Text] [Related]
19. Availability of dihydrofolate reductase affinity handle in expressing human prolactin as a soluble fusion protein.
Iwakura M; Morikawa M
Biosci Biotechnol Biochem; 1993 Nov; 57(11):1955-7. PubMed ID: 7764341
[TBL] [Abstract][Full Text] [Related]
20. Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.
Tsukamoto H; Fukudome K; Kohara J; Nakatake H; Kimoto M
Protein Expr Purif; 2007 Nov; 56(1):138-44. PubMed ID: 17703948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
